Antibodies against human cytomegalovirus late protein UL94 in the pathogenesis of scleroderma-like skin lesions in chronic graft-versus-host disease

International Immunology

Volumn 24, Issue 9, 2012, Pages 583-591

  Pastano, Rocco ^a   Dell'agnola, Chiara ^b   Bason, Caterina ^b   Gigli, Federica ^a   Rabascio, Cristina ^a   Puccetti, Antonio ^c   Tinazzi, Elisa ^b   Cetto, Gianluigi ^b   Peccatori, Fedro ^a   Martinelli, Giovanni ^a   Lunardi, Claudio ^b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Endothelial cell apoptosis; Fibroblast proliferation; Tetraspanin NAG 2

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY; CYTOMEGALOVIRUS ANTIBODY UL94; CYTOMEGALOVIRUS PROTEIN UL94; IMMUNOGLOBULIN G ANTIBODY; NAG 2 ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; APOPTOSIS; ARTICLE; CELL VIABILITY; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; DNA FRAGMENTATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; SCLERODERMA; SYSTEMIC SCLEROSIS;

ADULT; ANTIBODIES, VIRAL; APOPTOSIS; CAPSID PROTEINS; CELL PROLIFERATION; CELLS, CULTURED; CHRONIC DISEASE; CROSS REACTIONS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; ENDOTHELIUM, VASCULAR; FEMALE; FIBROBLASTS; GRAFT VS HOST DISEASE; HUMANS; MALE; MIDDLE AGED; MOLECULAR MIMICRY; SCLERODERMA, SYSTEMIC; SKIN; STEM CELL TRANSPLANTATION; TETRASPANINS; YOUNG ADULT;

EID: 84865555193     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxs061     Document Type: Article

References (30)

1. Remberger, M., Kumlien, G., Aschan, J. et al. 2002. Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. 8: 674.
2. Barrett, A. J. 1989. Graft versus host disease-clinical features and biology. Bone Marrow Transplant 4(Suppl. 4):18.
3. Deeg, H. J. and Storb, R. 1984. Graft-versus-host disease: pathophysiological and clinical aspects. Ann. Rev. Med. 35:11
4. Smith E. A. and LeRoy E. C. 1997. Connective tissue diseasesystemic sclerosis: ethiology and pathogenesis. In Klippel, J. and Dieppe, P.A., eds., Rheumatology. 2nd ed. Mosby Yearbook Europe Ltd, London.
5. LeRoy, E.C. 1996. Systemic sclerosis: a vascular perspective. Rheum. Dis. Clin. North Am. 22:675
6. Gabrielli, A., Avvedimento, E.V. and Krieg, T. 2009. Scleroderma. N. Engl. J. Med. 360:1989.
7. Kuhn, G., Jarzabek-Chorzelska, M., Blaszczyk, M., Kolacinska-Strasz, Z., Chorzelski, T.P. and Jablonska, S. 1989. The Scl-70 antibody and its clinical significance. Dermatol. Monatsschr. 175:133.
8. Furst, D.E., Clements, P.J., Graze, P., Gale, R. and Roberts, N. 1979. A sindrome resembling progressive systemic sclerosis after bone marrow trasplantation. Arthritis Rheum. 22:904.
9. Fialkow, P., Gilchrist, C. and Allison, A.C. 1973. Autoimmunity in chronic graft-versus-host disease. Clin. Exp. Immunol. 13:479.
10. Muryoi, T., Pasturi, K.N., Kafina, M.J. et al. 1992. Antitopoisomerase I monoclonal autoantibodies from scleroderma patients and tight skin mouse interact with similar epitopes. J. Exp. Med. 175:1103.
11. Bunn, C.C., Denton, C.P., Shi-Wen, X., Kight, C. and Black, C.M. 1998. Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis. Br. J. Rheumatol. 37:15.
12. Span, A.H.M., van Boven, C.P.A. and Bruggeman, C.A. 1989. The effect of cytomegalovirus infection of the adherence of polimorphonuclear leucocytes to endothelial cells. Eur. J. Clin. Invest. 19:542.
13. Pandey, J.P. and LeRoy, E.C. 1998. Human Cytomegalovirus and the vasculopathies of autoimmune diseases (especially scleroderma), allograft rejection, and coronary restenosis. Arthritis Rheum. 41:10.
14. Blum, A., Giladi, M., Weinberg, M., et al. 1998. High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis. Am. J. Cardiol. 81:866.
15. Jarvis, M. and Nelson, J. 2002. Human cytomegalovirus persistence and latency in endothelial cells and macrophages. Curr. Opin. Microbiol. 5: 403.
16. Guetta, E., Scarpati, E.M., Di Corleto, P.E. 2001. Effect of cytomegalovirus immediate early gene products on endothelial cell gene activity. Cardiovasc. Res. 50:538.
17. Lunardi, C., Bason, C., Navone, R. et al. 2000. Systemic sclerosis IgG autoantibodies bind the human cytomegalovirus late protein UL94 and induces apoptosis in human endothelial cells. Nat. Med. 10:1183.
18. Lunardi, C., Dolcino, M., Peterlana, D. et al. 2006. Antibodies against human cytomegalovirus in the pathogenesis of systemic sclerosis: a gene array approach. PLos ONE 3(1):e2.
19. Namboodiri, A.M., Rocca, K.M. and Pandey, J.P. 2004. IgG antibodies to human cytomegalovirus late protein UL94 in patients with systemic sclerosis. Autoimmunity 37:241.
20. Baström, L., Ringdén, O., Jacobsen, N., Zwaan, F. and Nilsson, B. 1990. A European multicenter study of chronic graft-versus host disease. The role of cytomegalovirus serology in recipients and donors: acute graft-versus-host disease, and splenectomy. Transplantation 49:1100.
21. Lönnqvist, B., Ringdén, O., Wahren, B., Gahrton, G. and Lundgren, G. 1984. Cytomegalovirus infection associated with and preceding chronic graft-versus-host disease. Transplantation 38:465.
22. Soderberg, C., Larsson, S., Rozell, B.L., Sumitran-Karuppan, S., Ljungman, P. and Moller, E. 1996. Cytomegalovirus-induced CD13-specific autoimmunity: a possibile cause of chronic graftvs-host disease. Transplantation 61:600.
23. Ruzek, M.C., Jha, S., Ledbetter, S., Richards, S.M. and Barman RD. 2004. A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease. Arthritis Rheum. 50:1319.
24. Bell, S.A., Faust, H., Mittermuller, J., Kolb, H.J. and Meurer, M. 1996. Specificity of antinuclear antibodies in sclerodermalike chronic graft-versus host disease: clinical correlation and histocompatibility locus antigen association. Br. J. Dermatol. 134:848.
25. Svegliati Baroni, S., Santillo, M., Bevilacqua, F. et al. 2006. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N. Engl. J. Med. 354:2667.
26. Svegliati, S., Olivieri, A., Capelli, N. et al. 2007. Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host-disease. Blood 110:237.
27. Boeckh, M., Leisenring, W., Riddell, S. R. et al. 2003. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood 101:407.
28. Ljungman, P., Aschan, J., Lewensohn-Fuchs, I. et al. 1998. Results of different strategies for reducing cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients. Transplantation 66:1330.
29. Larsson, K., Aschan, J., Remberger, M., Ringden, O., Winiarski, J. and Ljungman, P. 2004. Reduced risk for estensive chronic graftversus-host-disease in patients receiving transplants with human leukocyte antigen-identical sibling donors given polymerase chain reaction-based pre-emptive therapy against cytomegalovirus. Transplantation 77:526.
30. Traggiai, E., Lunardi, C., Bason, C. et al. 2010. Generation of anti-NAG-2 mAb from patients' memory B cells: implications for a novel therapeutic strategy in systemic sclerosis. Int. Immunol. 22:367.